These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29848564)

  • 1. Delafloxacin
    Pfaller MA; Flamm RK; McCurdy SP; Pillar CM; Shortridge D; Jones RN
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29848564
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    McCurdy S; Lawrence L; Quintas M; Woosley L; Flamm R; Tseng C; Cammarata S
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on the activity of delafloxacin against acute bacterial skin and skin-structure infection isolates from European hospitals (2014-2019).
    Shortridge D; Pfaller MA; Streit JM; Flamm RK
    J Glob Antimicrob Resist; 2020 Dec; 23():278-283. PubMed ID: 33068780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delafloxacin activity against Staphylococcus aureus with reduced susceptibility or resistance to methicillin, vancomycin, daptomycin or linezolid.
    Saravolatz LD; Pawlak JM; Wegner C
    J Antimicrob Chemother; 2020 Sep; 75(9):2605-2608. PubMed ID: 32542310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of 30/20-Microgram Disk Content versus MIC Results for Ceftazidime-Avibactam Tested against Enterobacteriaceae and Pseudomonas aeruginosa.
    Sader HS; Rhomberg PR; Huband MD; Critchley IA; Stone GG; Flamm RK; Jones RN
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29563198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reevaluation of Enterobacteriaceae MIC/disk diffusion zone diameter regression scattergrams for 9 beta-lactams: adjustments of breakpoints for strains producing extended spectrum beta-lactamases.
    Jones RN; Craig WA; Ambrose PG; Dudley MN; Pottumarthy S
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):235-46. PubMed ID: 16105568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Revised Ceftaroline Disk Diffusion Breakpoints When Testing a Challenge Collection of Methicillin-Resistant Staphylococcus aureus Isolates.
    Sader HS; Rhomberg PR; Doyle TB; Flamm RK; Mendes RE
    J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30257898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Broth Microdilution MIC and Disk Diffusion Antimicrobial Susceptibility Test Quality Control Ranges for the Combination of Cefepime and the Novel β-Lactamase Inhibitor Enmetazobactam.
    Belley A; Huband MD; Fedler KA; Watters AA; Flamm RK; Shapiro S; Knechtle P
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility of bovine mastitis pathogens to a combination of penicillin and framycetin: development of interpretive criteria for testing by broth microdilution and disk diffusion.
    Pillar CM; Stoneburner A; Shinabarger DL; Abbeloos E; Goby L; Bradley AJ
    J Dairy Sci; 2014 Oct; 97(10):6594-607. PubMed ID: 25129497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA. SPAR Study Group.
    Ballow CH; Jones RN; Johnson DM; Deinhart JA; Schentag JJ
    Diagn Microbiol Infect Dis; 1997 Nov; 29(3):173-86. PubMed ID: 9401810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Ciprofloxacin and Levofloxacin Disk Diffusion and Etest Using the 2019
    Humphries RM; Hindler JA; Shaffer K; Campeau SA
    J Clin Microbiol; 2019 Mar; 57(3):. PubMed ID: 30567744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Ceftazidime-Avibactam 30/20-μg Disk, Etest versus Broth Microdilution Results When Tested against
    Han R; Yang X; Yang Y; Guo Y; Yin D; Ding L; Wu S; Zhu D; Hu F
    Microbiol Spectr; 2022 Feb; 10(1):e0109221. PubMed ID: 35019685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of EUCAST zone diameter breakpoints and quality control range for Staphylococcus aureus with ceftaroline 5-μg disk.
    Koeth LM; Matuschek E; Kahlmeter G; Alm RA; Ambler JE
    Eur J Clin Microbiol Infect Dis; 2014 Sep; 33(9):1511-7. PubMed ID: 24744220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of interpretive criteria for tebipenem disk diffusion susceptibility testing with Staphylococcus spp. and Haemophilus influenzae.
    Fujisaki M; Sadamoto S; Ikedo M; Totsuka K; Kaku M; Tateda K; Hirakata Y; Yamaguchi K
    J Infect Chemother; 2011 Feb; 17(1):17-23. PubMed ID: 20676913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of sparfloxacin activity and spectrum against 24,940 pathogens isolated in the United States and Canada, the final analysis.
    Jones RN; Ballow CH; Schentag JJ; Johnson DM; Deinhart JA
    Diagn Microbiol Infect Dis; 1998 May; 31(1):313-25. PubMed ID: 9597392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance of omadacycline activity tested against clinical isolates from the United States and Europe: Results from the SENTRY Antimicrobial Surveillance Programme, 2017.
    Huband MD; Pfaller MA; Shortridge D; Flamm RK
    J Glob Antimicrob Resist; 2019 Dec; 19():56-63. PubMed ID: 30825698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in a Murine Lung Infection Model.
    Lepak AJ; Andes DR
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4764-9. PubMed ID: 27216072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary potencies of minocycline and tetracycline HCL tested against Gram-positive pathogens: SENTRY Program results using CLSI and EUCAST breakpoint criteria.
    Jones RN; Wilson ML; Weinstein MP; Stilwell MG; Mendes RE
    Diagn Microbiol Infect Dis; 2013 Apr; 75(4):402-5. PubMed ID: 23514756
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Kong Y; Li C; Li G; Yang T; Draz MS; Xie X; Zhang J; Ruan Z
    Microbiol Spectr; 2022 Jun; 10(3):e0009922. PubMed ID: 35532225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of fusidic acid (CEM-102) susceptibility testing reagents: broth microdilution, disk diffusion, and Etest methods as applied to Staphylococcus aureus.
    Jones RN; Castanheira M; Rhomberg PR; Woosley LN; Pfaller MA
    J Clin Microbiol; 2010 Mar; 48(3):972-6. PubMed ID: 20053856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.